tirzepatide patent status

tirzepatide patent status Generic Zepbound Explained: The Landscape Looming GLP-1 drug patent expirations

Name: tirzepatide patent status Generic Zepbound Explained: The Landscape Looming GLP-1 drug patent expirations
Brand: 2m-capital.com
SKU: 68174801199
Price: 21.38 USD
Availability: InStock
Rating: 4.5589 (14 reviews)

SKU: 68174801199

4.6

USD21.38 USD56.38

Pay in 4 interest-free payments of $5.34 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Nov 13 - Nov 18

Description

Often the first-line option for patients new to GLP-1 therapy

All products sold by Polar Peptides are intended strictly for research use only and are not intended for human consumption, medical use, diagnostic use, or any other unauthorized use

According to the FDA prescribing information, fatigue is not listed among the most common adverse reactions (occurring in 5% of patients) for Zepbound

The compounded tirzepatide they provide uses the same active ingredient as FDA-approved Mounjaro, but compounded products themselves are not evaluated by the FDA for safety, effectiveness, or quality